levofloxacin (500 mg/d) and mirodenafil (50 mg/d) (group ML) for six weeks	levofloxacin (500 mg/d) (group L, 40 patients) for 6 weeks	International Index of Erectile Function (IIEF) questionnaire	8668	8804	Group ML showed a significantly greater increase in the IIEF-EF score than group L (group L, +0.2 vs. group ML, +7.8; p<0.05) (Table 4).
levofloxacin (500 mg/d) and mirodenafil (50 mg/d) (group ML) for six weeks	levofloxacin (500 mg/d) (group L, 40 patients) for 6 weeks	maximum urinary flow rate or mean residual urine volume	8805	9004	No significant change from baseline to the end of treatment and no significant difference in maximum urinary flow rate or mean residual urine volume were observed between the two groups (Table 5, 6).
